Trademark: 90575161
Status Date
Tuesday, January 9, 2024
Filing Date
Friday, March 12, 2021
Published for Opposition
Tuesday, November 23, 2021
40 Custom manufacture of pharmaceutical, veterinary and diagnostic preparations and substances; custom manufacture of biopharmaceuticals; biomanufacturing for others, namely, processing of biopharmaceutical materials for others; consultancy services relating to manufacturing processes for pharmaceutical, veterinary and diagnostic substances; custom manufacture of recombinant proteins
5 Antibacterial pharmaceuticals; diagnostic veterinary preparations; diagnostic preparations for medical purposes; diagnostic preparations, namely, antigens and antibodies for medical purposes for use in disease testing; pharmaceutical, veterinary and/or diagnostic preparations and substances produced by biochemical and/or genetic engineering methods, namely, antivirals and diagnostic preparations for veterinary and medical use; reagents for medical purposes; tests and test kits for medical and pharmaceutical purposes, namely, drug testing kits comprised of medical diagnostic reagents and assays that testing bodily fluids
1 Chemical preparations for use in industry; chemicals used in science; reagents for scientific purposes; diagnostic preparations, namely, antigens and antibodies for scientific purposes; testing kits for scientific purposes predominantly consisting of reagents; proteins for industrial use, namely, antigens and antibodies; nucleic acids for laboratory use, namely, nucleic acid for the production of proteins produced by biochemical and/or genetic engineering methods
42 Scientific and technological services, namely, pharmaceutical and new product research and design; scientific research and development services; research in the chemical, medical, and/or biochemical field; development of pharmaceutical, veterinary medicine and medical diagnostic substances and products and pharmaceutical research regarding methods for the manufacture thereof, namely, using biotechnological and genetically-engineered means; process development services in relation to pharmaceutical, veterinary and diagnostic substances, namely, consulting regarding the development of pharmaceutical preparations and medicines; technical consultancy in the pharmaceutical, veterinary and diagnostic sector, namely, technical consulting in the field of pharmaceutical studies; new product development services in relation to recombinant protein technology and development
Jan 11, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 9, 2024
Sou Extension 4 Granted
Jan 9, 2024
Sou Extension 4 Filed
Jan 9, 2024
Sou Teas Extension Received
Jul 19, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 17, 2023
Sou Extension 3 Granted
Jul 17, 2023
Sou Extension 3 Filed
Jul 17, 2023
Sou Teas Extension Received
Jan 13, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 11, 2023
Sou Extension 2 Granted
Jan 11, 2023
Sou Extension 2 Filed
Jan 11, 2023
Sou Teas Extension Received
Jul 16, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 14, 2022
Sou Extension 1 Granted
Jul 14, 2022
Sou Extension 1 Filed
Jul 14, 2022
Sou Teas Extension Received
Jan 18, 2022
Noa E-Mailed - Sou Required From Applicant
Nov 23, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 23, 2021
Published For Opposition
Nov 3, 2021
Notification Of Notice Of Publication E-Mailed
Oct 20, 2021
Approved For Pub - Principal Register
Oct 20, 2021
Examiner's Amendment Entered
Oct 20, 2021
Notification Of Examiners Amendment E-Mailed
Oct 20, 2021
Examiners Amendment E-Mailed
Oct 20, 2021
Examiners Amendment -Written
Oct 12, 2021
Assigned To Examiner
Jun 12, 2021
New Application Office Supplied Data Entered
Mar 16, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
